Evaluating Clinical Efficacy of Antiviral Therapy for COVID-19: A Surrogate Endpoint Approach

INTRODUCTION: Efficient evaluation with an early surrogate endpoint, taking into account the process of disease evolution, may not only clarify inconsistent or underpowered results but also provide a new insight into the exploration of a new antiviral therapy for treating COVID-19 patients. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Jen, Hsiao-Hsuan, Chang, Wei-Jung, Lin, Ting-Yu, Hsu, Chen-Yang, Yen, Amy Ming-Fang, Lai, Chao-Chih, Chen, Tony Hsiu-Hsi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7972010/
https://www.ncbi.nlm.nih.gov/pubmed/33738764
http://dx.doi.org/10.1007/s40121-021-00431-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7972010/
https://www.ncbi.nlm.nih.gov/pubmed/33738764
http://dx.doi.org/10.1007/s40121-021-00431-9

Ejemplares similares